Shahrzad Shirazi Fard

2PUBLICATIONS
3CO-AUTHORS
Molecular targetsCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 30, 2021
Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines.

Linnéa Ödborn Jönsson, Maryam Sahi, Ximena Lopez-Lorenzo

|Jan 18, 2018
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma.

Isabell Hultman, Linnea Haeggblom, Ingvild Rognmo

Pageof 1

Frequent Collaborators

1 joint publications

Maryam Sahi

1 joint publications

Ximena Lopez-Lorenzo

1 joint publications

Nikolas Herold